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The synthesis of the arylnaphthalene lignan haplomyrtin using vanillin as a 
starting material is synthesized via: 1) a bromination of vanillin, 4-hydroxy-5-
methoxybenzaldehyde, to produce 6-bromovanillin 2) a hydroxyl protection step of 6-
bromovanillin with triisopropylsilylchloride to produce 2-bromo-4-triisopropylsilyoxy-5-
methoxybenzaldehyde 3) an aldehyde protection step through a cyclic acetal formation 
using ethylene glycol to produce 2-(2-bromo-4-triisopropylsilyloxy-5-methoxyphenyl)-
1,3-dioxolane  4) a lithium for halogen exchange of the doubly protected 6-bromovanillin    
leads to neucleophilic coupling with piperonal  producing 1,3-benzodioxol-5-yl-[5-
triisopropylsilyloxy-2-(1,3-dioxolane-2-yl)-4-methoxyphenyl]methanol and 5) an acid 
catalyzed  intramolecular cycloaddition /Diels Alder adduct with dimethyl 
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The genus Haplophyllum, belonging to the rutaceae family, or “citrus type 
plants,” is well represented1 by approximately seventy different plant species that are 
found across most of the European continent.2 Haplomyrtin 1, was first reported isolated 
 
 1 2 3 
from the perennial Turkish herb, Haplophyllum myrtifolium in 1985. The synthetic 
challenge to produce Haplomyrtin was first addressed by Gilmore3 in 1996 and by 
various other researchers4,5,6,7 over the next sixteen years. Low product purity, low yields, 
and poor intermediate stability have plagued these synthetic attempts. A lithium-halogen 
exchange reaction involving benzyl ether 2 is hampered by the benzyl methylene acidity 
that has been clearly identified by D2O quenching studies. This suggests that the 
preparation of 38 may circumvent these problems. 
The objectives of this research were to 1) use 3 to prepare the TIPS analog of 2, 









The discovery that certain plant hormones exhibit anticancer properties has 
generated considerable interest in a possible synthetic route to their production. The 
chemical diversity of alkaloids present in the rutaceae family correlate well with the 
various biosynthetic pathways of the aromatic amino acid precursors found in the human 
body, i.e. tyrosine, tryptophan, histidine, and anthranilic acid.9 The interest in these 
rutaceous, polyheterocyclic alkaloids’ use as potential anticancer agents relies on their 
unique abilities to interact with and disrupt DNA replication through the binding at 
specific covalent adduction sites on the nucleic acid chains. Many such targeted plant 
compounds, or lignans, exist naturally in low part per million amounts, necessitating 
alternative, more practical, means to their production. Seven of the most widely used 
chemotherapeutic drugs today are still derived from plant origin, i.e., Etoposide and 
Teniposide  (from the American Mayapple Podophyllum peltatium)), Taxol (from the 
Pacific Yew bark, Taxus brevifolia ), Vinblastine and Vincristine (from periwinkle 
leaves, Vinca rosea Linn.), Topotecan and Irinotec (from the Chinese Happy Tree bark, 
Camptotheca acuminate).10 
The plant arylnapthalene phenol “Haplomyrtin” was first isolated, structurally 
identified, and reported through the efforts of Gözler in 1985 from a dried, finely divided 
sample of Haplophylum myrtifolium. A crushed, herbal, EtOH extract was acidified, 
extracted with CHCl3, fractionalized by way of a silica gel column, dried, and one 
alkaloid (of several reported), Haplomyrtin, was obtained in the form of a white 
 3 
amorphous powder. The combined efforts of Ege University, College of Pharmacy in 
Izmir, Turkey and Penn State University, Department of Chemistry, confirmed the 
structure was that of Haplomyrtin via 1H NMR, UV, IR, and mass spectral data. 
Haplomyrtin 1 is only one of hundreds of reported naturally occurring 
arylnaphtalene lignans that can be found in a number of species of the Turkish perennial 
herb genus, Haplophyllum. Haplomyrtin 1 has also been isolated from certain varieties of 
the Phyllanthus genus of which there are over 600 reported species distributed throughout 
South America, Asia, and Africa. The arylnapthalene scaffolding central to haplomyrtin’s 
structure has readily been synthesized in several commonly used drug intermediates, i.e. 
Justicin B 4, Taiwanin C 5 and Diphyllin 6, of which there are well over 200 
derivatives.The primary differences and overall challenge faced with the synthetic route 
to Haplomyrtin vs. one of the more common structures, as has been shown, stems from 
the difficulty of introducing and protecting hydroxyl groups at the C4 and C7 positions of 
Haplomyrtin’s naphthalene nucleus. 
 





The synthesis of the plant-phenol, Haplomyrtin 1, was first attempted at WSU by 
Gilmore in 1996.3 Through a combination of both literature search and ingenuity, he 
proposed a synthetic route utilizing the readily available ingredients, vanillin 7 and 
piperonal 12a as starting materials. In twelve separate steps, he did manage to produce a 
crude, non-isolatable product, that via 1H NMR, resembled Haplomytin 1. All subsequent 
research and refinements into the synthesis of this compound were based on Gilmore’s 
initial efforts. 
In order to build the arylnaphthalene nucleus of 1, Gilmore chose to begin with 
the “A” ring portion of which vanillin is used as the starting point. Bromination of 
vanillin at the desired 6 position of the aromatic ring is strategically accomplished 
through ring deactivation of vanillin’s ortho directing hydroxyl group by the addition of 
the acetyl group followed by bromination in acetic acid in order to produce acetylated 6-
bromovanillin 9. 
 
 7 8 9 
Prior to the ensuing lithium halogen exchange step used to insert the pendent “C” ring on 
to the 6 position of 6-bromovanillin “A”-ring nucleus, double protection of the hydroxyl 
and aldehyde functions of 6-bromovanillin is needed. The 4-hydroxyl group protection of 
10 is accomplished through capping via the benzyl ether formation reaction with benzyl 





 9 10 11 
 
 12 12a 13 13a 
 
 14 15 
 
 15a 1 
reaction with trimethyl orthoformate. The newly protected precursor, 2-bromo-4-
benzyloxy-5-methoxybenzaldehyde dimethylacetal 12, may now undergo a lithium-
bromine exchange. Utilizing butyl lithium to generate a lithiated carbanion product 
intermediate of 12, the newly formed nucleophile can attack the piperonal aldehyde 
 6 
generating the target alcohol 13. Acid-catalyzed hydrolysis of the dimethyl acetal to the 
alcohol 13 allows for an intramolecular condensation followed by cyclization, thereby 
generating an intermediate isobenzofuran 13a. The Diels-Alder product of the reaction of 
the intermediate diene 13a with the dienophile, dimethyl acetylenedicarboxylate 
(DMAD), generates the targeted “A-B-C” ring napthol precursor 14. Prior to the final 
two steps in forming the terminal butyrolactone ring of the target product, the benzyl, 
protecting group at C7 must first be removed through catalytic hydrogenation, leaving the 
diol product, napthol 15. In order to complete butyrolactone ring formation in the final 
step, the ortho ester function on C3 of 15 is selectively reduced to the primary alcohol 
intermediate 15a utilizing NaBH4 prior to acid catalyzed, intramolecular condensation 
that in turn produces 1. 
Schaaf Refinements 
Refinements to the Gilmore procedures were first reported in 1998 by Schaaf.4 
Although Schaaf did not succeed in producing 1, his research efforts focused towards the 
added synthetic burdens created through the required vanillin 7 protection steps. First, 
Schaaf demonstrated the use of a more “compact” cyclic acetal (in 16) protective group 
 
 11  16 
 
 12 13 
 7 
at the C1 aldehyde in place of Gilmore’s more sterically demanding dimethoxy function 
(in 12). Second, Schaaf demonstrated the issue of proton lability of the C4 benzylic 
protecting group of 7 through BuLi metalation, followed by D2O workup, thus producing 
the conjugate deuterated acid product. Third, he demonstrated that a possible alternative 
“Grignard route” to the desired alcohol intermediate 13 was not effective and was not a 
viable alternative to lithium halogen exchange. 
Chirisa Refinements 
Further refinements to the Gilmore procedure were demonstrated by Chirisa in 
2006.5 First, Chirisa substantially improved the yield of 6-bromovanillin 10 through 
alternate procedural chemistry. Second, she demonstrated through 1H NMR studies that 
the ideal stoichiometric ratio of butyl lithium to protected precursor 12 during halogen 
exchange step is 1:1. Third, she reiterates the reactivity issue associated with the benzyl 
protective group and it’s problematic involvement during the lithium-halogen exchange 
step. An isolated end product 1 in low yield was obtained. 
Hunter Refinements 
In 2008, Nora Hunter‘s research at WSU on total Haplomyrtin synthesis6 again 
focused on the lithiation reaction difficulties associated with the benzyl ether protection 
at C4 of the bromovanillin acetal nucleus. In an effort to decrease the susceptibility of the 
 
 
 16a 16b 
 8 
protective group benzylic protons on C4, Hunter introduced the p-methoxybenzyl (PMB) 
protection group 16a in an effort to increase the benzylic pka. The PMB protection, 
however, soon proved to be problematic. Second, her modification of the acid catalyzed 
DMAD Diels-Alder cycloaddition step utilizing catalytic amounts of pTSA in place of 
acetic improved yields of the targeted arylnapthalene diester product 14 over previous 
researchers. An isolated end product was not produced. 
Coen de Oude Refinements 
Most recently, in 2012, de Oude7 researched a variant synthetic route to 
Haplomyrtin that paralleled the patented “Cleistantin A” procedure.12 Cleistantin A, also 
an arylnaphthalene lignin is structurely similar to Haplomyrtin’s arylnaphthalene nucleus 
but with key differences being the C7 substituents. Cleistantin A contains the stable 
methyl ether group whereas Haplomyrtin has the problematic hydroxyl function. Key 
synthetic changes include 1) longer lithium halogen reaction times by a factor of 5 and at 
a higher temperature, 2) an ammonium chloride solution quench of 17, 3) the DMAD 
cycloaddition step carried out in sealed tube conditions and 4) LAH reduction of 
dicarboxylate intermediate 15 in place of NaBH4. A crude, non-isolatable product was 
obtained in low yield. 
 
 17 14 
 9 
 
 15 1 
Silyl Protecting Groups 
The silyl ethers, R3SiOR′ 19, are one of the most frequently used groups for the 
protection of the hydroxyl function. They are commonly synthesized by the reaction of an 
alcohol or a phenol R′ with a trialkylsilyl chloride 18 in the presence of an organic base 




 18 19 
Figure 1. Imidazole catalysis of alcohol/phenol reaction with a trialkysilyl chloride. 
Their popularity also stems from the fact that they are readily introduced and 
removed under mild conditions.13 The ability to regulate both steric and electronic effects 
on the silicon atom through the selective use of attached substituents makes silyl ethers a 
valuable, multifunctional tools. Silyl ethers can be easily cleavable through select use of 
compact steric attachments as in the trimethylsilyl (TMS) 21 or made relatively inert to 
 10 
 
 TMS TES TBDMS TIPS TBDPS 
 20 21 22 23 24 
 
the harshest conditions as in TBDPS 24. These steric effects can also be advantageous in 
regiospecific alcohol protection. The large, more sterically demanding TIPS, TBDMS, 
and TBDPS groups will selectively bind to primary alcohols in the presence of hindered 
secondary and tertiary OH groups.14 The compact TMS can be used to cap the most 
hindered tertiary alcohols. The cleavability of silyl ethers is also dependent upon 
constituent electronic effects. Electron withdrawing groups on the silicon atom increase 
susceptibility toward base hydrolysis but decrease sensitivity towards acid.15 The stability 
toward acid hydrolysis of the silyl ethers (relative rates) shown earlier increases in the 
following order: TMS (1) < TES (64) < TBDMS (20,000) < TIPS (700,000) < TBDPS 
(5,000,000), and stability towards base increases in the following order: TMS (1) < TES 
(10-100) < TBDMS~TBDPS (20,000) < TIPS (100,000).14 The TIPS group is easily 
introduced, is inert under many conditions, is easily removed by specific reagents thus 
rendering TIPS one of the foremost permanent protecting groups for OH. The bulkiness 
of TIPS seems to be the correct magnitude as to exhibit a good compromise between 
useful steric effects on the one hand and ease of removal on the other. 
2-Bromo-5-methoxy-4-triisopropylsilyloxybenzaldehyde 
The synthesis of 2-bromo-5-methoxy-4-triisopropylsilyloxybenzaldehyde 24 was 
reported in 2004.8,15 Aldehyde 10 was reacted with triisopropylsilyl chloride in DMF 
 11 
using imidazole as a catalyst to produce the TIPS protected aldehyde 24. Subsequent 
reduction of 24 with sodium borohydride produced an intermediate alcohol that could be 
converted to the bromide 25 by reaction with phosphorus tribromide. The bromide 25 
was used to produce a substituted tetrahydroisoquinoline for rearrangement studies. 
 
 10 24 25 
Lithium/Halogen Exchange Reactions 
One crucial step in the assembly of the Haplomyrtin nucleus is the 
lithium/halogen exchange reaction. The organo-lithiums, due to the highly polar nature of 
the electron deficient lithium atom, can only exist in a hydrocarbon solution through 
stabilized aggregates of hexamers, tetramers, and dimers.16 This particular aggregate state 
will depend upon the steric nature of the individual organolithium and the stabilizing 
solvent system. In an alkane hydrocarbon the highly branched alkyl or benzyl lithiums 
may only exist as the dimer whereas the straight chain n-butyl lithium as the hexamer. 
The use of an electron donating solvent system, such as an ether or amine base, may 
function as a coordinating ligand allowing the organolithium to shift to a lower degree of 
aggregation.17,18,19 In general, organolithium reactivity, i.e., metallation strength, rises 
with the Lewis basicity of the solvent system. The reactivity of organolithiums can 
therefore, in part, be modulated by choice of solvent system. The highly polar amine 
HMPA is very activating, THF and TMEDA are moderately activating, with diethyl ether 
the least. However, the de-aggregation effect of the solvent system alone doesn’t always 
explain the reactivity differences between the various solvents. The solvent properties 
 12 
may have more to do with stabilization of the reactant transition state or product than 
solely de-aggregating effects, but it is unclear how. All of the coordinating solvents used 
with the organolithiums, however, will eventually react with the organolithium, itself, 
over time. The attention to reaction time, maintaining very low temperature, and a quick 
workup are all necessary steps to avoid possible solvent decomposition products. 
      The mechanism of lithium halogen exchange is still unclear but the evidence suggests 
3 possible routes. Apparent in lithium halogen exchange is an equilibrium reaction 
favoring formation of the weaker, more stable organolithium conjugate base. The 
transition state involved in this process may be either 1) single electron-transfer (radical 
process), 2) nucleophilic (formation of halogen “ate” complex), or 3) four-centered 
complex model. 
 
Figure 2. Single electron transfer (SET) radical process. 
 
Figure 3. Nucleophilic  attack on halogen “ate” complex. 
 




A synthetic route to Haplomyrtin has been a decade-long-plus subject of graduate 
research at Wright State University’s (WSU) Feld Group. The synthetic difficulties 
encountered en route to this compound can be traced back to the necessary, but often 
problematic, protection and deprotection reaction steps. The following research focuses 
on the crucial naphthalenediol segment of Haplomyrtin 1. A new silyl ether protection in 
place of a previously used benzylic ether protection is proposed as shown in Figure 5. 
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Instrumentation and Chemicals 
Melting points were obtained with a DigiMelt MPA-160 or Electrothermal MP 
Apparatus. Nuclear magnetic resonance (NMR) 1H and 13C spectra were obtained using a 
Bruker Avance 300 MHz NMR Spectrometer. Solvents for NMR were CDCl3 and 
DMSO-d6. Infrared (IR) spectra were recorded as thin films (NaCl) with a Nicolet 6700 
FT-IR spectrometer. Elemental analyses were obtained through Midwest Microlab, LLC, 
Indianapolis, IN. A 35 mL Q-Tube™ (pressure tube reactor) was purchased from Sigma-
Aldrich Labware. Chemicals were purchased from Aldrich and used as received. 
4-Acetoxy-3-methoxybenzaldehyde 8 
Vanillin 7 (60 g, 0.38 mol) was suspended in methylene chloride (300 mL). 
Acetic anhydride (45 mL, 0.48 mol) and pyridine (38 mL, 0.47 mol) were added. The 
solution was stirred for 18 h at rt. Water (100 mL) was added cautiously and the solution 
was extracted with ethyl acetate (2 x 100 mL). The organic layers were combined, 
washed with 1N HCl (2 x 100 mL), saturated NaHCO3 (2 x 100 mL), saturated brine (2 x 
100 mL) and dried over Na2SO4. The drying agent was filtered and the solution was 
concentrated under reduced pressure to yield 8 (68 g, 0.35 mol, 91%): mp 76° (lit5 77-
79°); IR(cm-1) 2966 (CH3), 2846 (CH3), 1753 (ester C=O), 1722 (ald C=O), 1219 (C-O), 
1200 (C-O); NMR (CDCl3) δ 2.34 (3H, s, CH3), 3.90 (3H, s, CH3COO); 7.22 (1H, d (J = 




Glacial acetic acid (190 mL) and acetylvanillin 8 (68 g, 0.35 mol) were 
introduced into a 100 mL round-bottomed-flask equipped with stir bar and pressure 
equalizing dropping funnel. A bromine solution, (43.7 g, 0.27 mol, 14 mL in 40 mL 
glacial acetic acid) was added dropwise. When addition was complete, acetic acid (140 
mL) was added followed by dropwise addition of 30% H202 (20.5 g, 0.60 mol). After 20 h 
the reaction was quenched by the addition of water (5 x 300 mL), cooled to 0° with ice, 
and the resultant precipitate was filtered and dried to give 9 (64 g, 0.24 mol, 67%): 1H 
NMR (CDCl3) δ 2.35 (3H, s, CH3), 3.89 (3H, s, CH3COO), 7.38 (1H, s, Ar-5H), 7.52 
(1H, s, Ar-2H), 10.28, 1H, s, -CHO). 
2-Bromo-4-hydroxy-5-methoxybenzaldehyde (6-bromovanillin) 10 
Into a 500 mL round-bottomed flask equipped with a condenser was added HCl 
(250 mL, 6N) and compound 9 (11 g, 0.04 mol). The mixture was refluxed at 90° for 4 h, 
cooled and the solids were filtered and recrystallized from EtOH to give 10 (2 g, 0.009 
mol, 22%): mp 176° (lit5 mp 178-180°); IR (cm-1) 3295 (O-H), 1660 (C=O), 1210 (C-O), 
694 (Ar-OH), 637  (Ar-Br); 1H NMR (CDCl3) δ 3.84 (3H, s, CH3), 7.09 (1H, s, Ar-5H), 
7.32 (1H, s, Ar-2H), 10.00 (1H, s, –CHO), 10.77 (1H, s, Ar-OH). 
 2-Bromo-5-methoxy-4-(triisopropylsilyloxy)benzaldehyde 24 
Imidazole (3.872 g, 56.8 mmol) and TIPSCl (3.096 g, 16.2 mmol) were added to a 
stirred solution of 2-bromo-4-hydroxy-5-methoxybenzaldehyde (BV) 10 (3.750 g, 16.2 
mmol) in dry DMF (50 mL). The reaction mixture was stirred for 15 min at room 
temperature and poured into water (150 mL). The product was extracted with hexane (3 x 
100 mL). The extracts were combined and washed with brine (100 mL) and dried over 
 16 
Na2SO4. The solution was filtered and the solvent was removed in vacuo to afford the 
title compound 24 as an amber oil (1.5 g, 3.8 mmol, 23.4%): IR (cm-1) 2944 (CH3), 2892 
((CH3)2C-H), 2867 (CH3), 1686 (C=O), 1387, 1322, 1153 ( (CH3)2C-H), 1213, 1042  (C-
O-C), 636 ( Ar-Br); 1H NMR (CDCl3) δ 1.11 (18H, d (J = 6.99 Hz), (CH3)2CH-)), 1.28 
(3H, m (J = 6.60 Hz), (CH3)2CH-)), 3.86 (3H, s, -OCH3), 7.09 (1H, s, Ar-6H), 7.42 (1H, 
s, Ar-3H), 10.19 (1H, s,-CHO); 13C NMR ppm 12.93, 17.73 (iPr3Si), 55.56 (-OCH3), 
111.23 (Ar-2C-Br), 119.44 (Ar-6C-H), 124.58 (Ar-3C-H), 126.98 (Ar-1C-CHO), 150.85 
(Ar-4C-OSi), 152.11 (Ar-5C-OCH3), 190.90 (-CHO). 
2-(2-Bromo-4-triisopropylsiloxy-5-methoxyphenyl)-1,3-dioxolane 26 
The aldehyde 24 (1.00 g, 2.6 mmol) and ethylene glycol (1.5 mL), pTSA (0.03 g) 
and benzene (90 mL) were introduced into a 100 mL round-bottomed flask equipped with 
a Dean-Stark trap (DST) and the solution was refluxed for 24 h. The water/benzene 
azeotrope was removed (3 x 10 mL) from the DST during reflux. The reaction was 
cooled and the solution was washed with saturated NaHCO3 solution (3 x 20 mL). The 
organic layer was dried overnight over Na2SO4, filtered, and the solvent removed in 
vacuo. The yellow oil was passed through a short silica gel column using ethyl 
acetate/hexane (1:5) to afford the title compound 26 (0.249 g, 0.58 mmol, 22%): IR (cm-
1) 2945 (CH3), 2892 ((CH3)2C-H), 2867 (CH3), 1387 ((CH3)2C-H), 1208 (ArOCH3),  1168 
(OCH2CH2O), 1087 (CHOCH2), 614 (Ar-Br); 1H NMR (CDCl3) δ 1.00 (18H, d (J = 7 
Hz), (CH3)2CH-), 1.16 (3H, m (J = 6.8 Hz), (CH3)2CH-), 3.73 (3H, s, -OCH3), 4.12 (4H 
m, -OCH2CH2O-), 5.90 (1H, s, -OCHO-), 6.96 (1H, s, Ar-6H), 7.19 (1H, s, Ar-3H); 13C 
NMR (CDCl3) ppm 12.75 (-CH-Si), 17.73(CH3)2CH-Si), 55.57 (-OCH3), 65.42 (–
OCH2CH2O-), 102.65 (-OCHO-), 110.90 (Ar-2C-Br), 112.76 (Ar-6C-H), 124.20 (Ar-
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1C-CH), 128.72 (Ar-3C-H), 147.07 (Ar-4C-OSi), 150.26 (Ar-5C-OCH3); Analytical 




In a flame-dried, sealed and purged, 15 mL, round-bottomed flask, piperonal 
(0.61 g, 4.1 mmol) was dissolved in dry THF (10 mL). In another dried, sealed, and 
purged 50 mL round-bottomed flask 26 (1.76 g, 4.1 mmol) was dissolved in anhydrous 
THF (25 mL). The 26 solution was transferred to a flame-dried, sealed, two-necked, 50 
mL round-bottomed flask equipped with a 10 mL pressure-equalizing dropping funnel, 
nitrogen inlet and outlet and the system was cooled to -78°. To the stirred, cooled 
solution was added dropwise, n-butyllithium (3 mL, 4.8 mmol, 1.6M). After addition of 
n-BuLi to the 26 mixture was complete, it was stirred for 0.5 h. The piperonal solution 
was transferred to the 10 mL dropping funnel and added dropwise to the reaction 
mixture. After stirring for 1 h at -78°, the reaction was allowed to warm to room 
temperature and stirred for an additional 5 h. The reaction was quenched with saturated 
NH4Cl (20 mL), extracted with ethyl acetate (3 x 20 mL) and the extracts were dried over 
NaSO3, filtered, and concentrated to give the intermediate alcohol 27 as a viscous amber 
oil that was used in the next step without further purification: IR(cm-1) 34634(OH);1H 
NMR (CDCl3) δ 7.28 (1H, s, Ar-6H), 7.08 (1H, d, Ar-6’H), 6.88 (1H, s, Ar-3H), 6.79 
(1H, s, Ar-2’H), 6.68 (1H, d, Ar-5’H),5.96 (1H, s, -OCH2O-), 5.95 (1H, s, -OCH2O-), 
5.92 (1H, s, -OCHO-), 5.91 (1H, s, -CHOH), 4.18 (2H, m, -OCH2CH2O-), 4.05 (2H, m, -







To a 35 mL sealed Q-tube was added the 1.94 g of crude 27, 0.39 mL (3.07 
mmol) of DMAD, 1.5 mL DCM, 0.89 mL (0.87 mmol) glacial acetic. The mixture was 
heated at 140° for 84 h. The reaction mixture was cooled, diluted with 30 mL of DCM, 
washed with NaHCO3 (3 x 10 mL), dried with NaSO3, filtered, and concentrated to give 
28 as a viscous oil that partially crystallized on standing: mp 141°; 1H NMR (CDCl3) δ 
0.98 (18H, d, (J = 6.78 Hz), (CH3)2CH-), 1.10 (3H, m, J = 6-7.4 Hz), (CH3)2C-H, 3.61 
(3H, s, -OCH3), 3.93 (3H, s, -OCOCH3), 3.97 (3H, s, -OCOCH3), 5.98 (1H, d, -OCH2O-, 
J = 1.38 Hz), 6.3 (1H, d, -OCH2O-, J = 1.38 Hz), 6.73 (1H, dd, Ar-6’H, J = 7.8, 1.65 Hz), 
6.756 (1H, d, Ar-4’H, J = 1.44 Hz), 6.813 (1H, s, Ar-5H),6.81 (1H, d, Ar-7’H), 7.7 (1H, 
s, Ar-8H), 12.31 (1H, s, Ar-OH ); 13C NMR (CDCl3) ppm (12.63, (-CH(CH3)2), 17.71, 
((CH3)2CH-), 51.92, (-OCOCH3), 52.71, (-OCOCH3), 55.70, (-OCH3), 100.85, (-
OCH2O-), 103.3*, (Ar-C5), 107.94, (Ar-7’C), 111.29, (Ar-4’C), 115.29*, (Ar-8C), 
120.34, (Ar-C), 124.12, (Ar-6’C), 127.57*, (Ar-5’C), 127.92*, (Ar-3C), 130.77* Ar-C, 
132.31*, Ar-C, 147.04*, Ar-C, 147.25*, Ar-C, 149.50*, Ar-C, 151.96*, Ar-C, 159.73*, 







RESULTS AND DISCUSSION 
In order to construct Haplomyrtin 1 from the starting materials 3-methoxy-4-
hydroxybenzaldehyde (vanillin) 7, 1,2-benzodioxole-5-carboxyaldehyde (i.e., piperonal) 
and dimethyl acetylenedicarboxylate (i.e., DMAD), several synthetic challenges must be 
overcome. These steps include 1) attachment of a 1,3-benzodioxole “C” ring to the C6 
position of vanillin, 2) a Diels-Alder cycloaddition to create a naphthalene “B” ring and 
3) the formation of a butyrolactone ring through reduction and cyclization of a “B” ring 
ortho ester, as shown in Figure 6. 
 
Haplomyrtin 1 
Figure 6. General retrosynthetic scheme for the construction of Haplomyrtin 1. 
 The first step in creating the naphthalene nucleus of 1 involves intentional 
deactivation of the trisubstituted ring of vanillin 7 via acetylation, followed by 
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 The first procedure followed to arrive at the targeted 6-bromovanillin 10 was that 
originally outlined by Gilmore. This procedure, however, soon proved to be problematic 
with only miniscule yields of final product. An alternative bromination reaction was, 
therefore carried out using a modified procedure of Ratton, et. al.18 The 1H NMR 
spectrum (Figure 7) of 9 shows a comparison between the two reaction results. The 
aldehyde singlet proton absorption of starting material 8 is at 9.95 δ while the aldehyde 
singlet proton absorption of 9 is further downfield at 10.28 δ. The 1H NMR spectra 
(Figure 7) showed that the product from the Gilmore procedure (top spectra) contains as 
much unreacted 8 as 9 while the product of the Ratton, et. al. procedure (bottom spectra) 
showed a marked increase in the targeted 9. The differences between the modified Ratton 
procedure and the original are 1) use of 30% hydrogen peroxide which regenerated 
bromine from the bromide by product and 2) longer reaction times (20 h). The yield of 
the intermediate product 5-bromo-4-formyl-2-methoxyphenylacetate 9 was improved to 
67%, however the overall yield of 10 after deacylation of 9 and final recrystallization was 
only 22%. The IR spectrum (Figure 8) of 8 indicates the loss of vanillin hydroxyl 
stretching adsorption in the 3500 cm-1 region and the appearance of a strong acetyl 
carbonyl stretching absorption at 1753 cm-1. The 1H NMR (Figure 9) of 8 shows the 
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acetyl methyl adsorption at 3.88 δ along with loss of the hydroxyl adsorption at 10.77 δ 
for vanillin. The 1H NMR (Figure 10) of 9 resulting from the bromination of 8 shows a 
shift of the aldehyde proton adsorption to 10.28 δ (from 9.90 δ) and two singlet aromatic 
para proton adsorptions at 7.37 δ and 7.52 δ. Deacylation of 9 to the phenol 10 is evident 
in the IR spectrum (Figure 11) which shows a broad hydroxyl stretching absorption at 
3295 cm-1, aromatic aldehyde adsorption shift to 1660 cm-1, and a strong carbon-bromine 
stretch at 636 cm-1. The 1H NMR (Figure 12) of 10 shows the reappearance of the 
hydroxyl singlet absorption at 10.77 δ along with the loss of the acetyl methyl singlet at 
2.34 δ. 
The protection of the hydroxyl group in 10 utilized triisopropylsilyl chloride and 
imidazole and yielded the target compound 24 quickly at room temperature following the 
procedure of Blank, et. al.16 The IR spectrum (Figure 13) of 24 lacks the characteristic 
broad hydroxyl absorption in the 3300 cm-1 region and is replaced with a strong aliphatic 
carbon hydrogen absorption resulting from the TIPS protection group and an aromatic 
aldehyde adsorption shift to 1686 cm-1 The 1H NMR of 24 (Figure 14) contains upfield 
adsorptions characteristic of the new TIPS group consisting of an 18 proton methyl 
doublet absorption at 1.11 δ and a 3 proton septet absorption at 1.28 δ. The hydroxyl 
proton singlet absorption at 10.77 δ is absent. The 13 C NMR spectrum of 24 (Figure 15) 
displays the expected 13 unique carbon absorptions characterizing this compound; 
isopropyl methyl at 17.73, isopropyl tertiary CH at12.93, methoxy methyl at 55.56, the 
six aromatics with Ar-2C-Br at 111.23, Ar-6C-H at 119.44,, Ar-3C-H at 124.58, Ar-1C-
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The final protection of 24 involved acetal formation of the susceptible aldehyde 
function utilizing an acid catalyzed dehydration procedure with ethylene glycol to 
generate the diprotected 26. Since dehydration is a reversible reaction, the water by-
product must be constantly removed in order to maintain equilibrium toward the product. 
This was accomplished through an azeotropic separation technique utilizing a Dean Stark 
apparatus along with diligent removal of the trapped water. The initial experimental 
procedure followed (Anson, et. al.23) called for stoichiometric amounts of pTSA catalyst 
which soon proved to be problematic. The target product 26 was plagued by the presence 
of almost equivalent amounts of unreacted 24 following workup and purification. A 
higher boiling solvent (i.e., toluene 120° vs. benzene 90°) was tried assuming the 
increased reaction temperature might lead to more complete water removal but with 
similar results. A decrease in pTSA by almost a factor of 10 to catalytic amounts was 
finally tried along with increased reaction times (i.e. 20-24 h vs. 6 h). This resulted in an 
improved yield (i.e., over 90%) of the pure 26 vs the 26/24 (i.e., 50:50) mixtures 
previously obtained. The 1H NMR spectrum (Figure 19) displays the outcome of the 
various reaction methods employed. The reaction conditions leading to 26 have been 
summarized in (Table 1). 
The final product purification was done by silica gel column chromatography 
utilizing a hexane/ethyl acetate (5:1) mobile phase followed by concentration under 
reduced pressure to yield a reasonably pure 26, suitable for the ensuing BuLi step. 
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Table 1. Reaction conditions towards the production of 26. 
1H NMR 









1 6.1 31.6 2.3 24 
2 2.9 13.7 2.4 22.5 
3 1.37 6.50 0.47 6.6 
4 1.55 8.77 0.44 24 
5 2.58 26.30 0.15 24 
 
The primary IR (Figure 16) spectral evidence for conversion of 24 to 26 is the 
appearance of a 1,3-dioxolane-2-yl tertiary carbon hydrogen stretch adsorption at 2892 
cm-1, and a 1,3-dioxolane asymmetric aliphatic ether stretching absorption at 1087 cm-1. 
The carbonyl stretch absorption at 1686 cm-1 is absent. The 1H NMR spectrum (Figure 
17) of 26 shows a 1,3-dioxolane-2-yl one proton singlet at 5.90 δ, a 1,3-dioxolane 
methylene four proton multiplet at 4.12 δ, a methoxy methyl three proton at 3.82 δ, a 
triisopropyl tertiary three proton septet at 1.24 δ and a six methyl eighteen proton doublet 
at 1.09 δ. The aldehyde one proton singlet absorption is absent at 10.19 δ. The 13C NMR 
spectrum (Figure 18) of 26 shows the expected eleven unique carbon adsorptions; 
isopropyl methyl at 17.88, isopropyl tertiary CH at 12.91, methoxy methyl at 55.59, the 
1,3-dioxolane methylenes at 65.35, the dioxolane methine at 102.74 ppm, and the six 
aromatics with Ar-1C at 110.99, Ar-2C at 128.72, Ar-3C at 112.88, Ar-6C at 124.28, Ar-
5C at 147.10, and Ar-4C at 150.42. The DEPT135 (Figure 20) spectrum shows isopropyl 
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CH at 12.94, isopropyl CH3 at 17.92, methoxy CH3 at 55.63, 1,3-dioxolane CH2 at 65.40, 
1,3-dioxolane CH at 102.77, Ar-3 CH at 110.97, and Ar-6 CH at 124.34. 
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The diprotected 26 was then subjected to the lithium-halogen exchange procedure 
followed by piperonal addition and workup to yield the intermediate chiral alcohol 27. In 
an effort to minimize complications from the unstable intermediate, the crude 27 was 
taken directly to the next step without further purification. The IR (Figure 21) spectrum 
of the crude 27 reaction product clearly indicates the formation of the alcohol. The IR of 
27 shows the appearance of a broad absorption at 3474 cm-1 resulting from hydroxyl 
stretching. The 1H NMR (Figure 22), although impure, shows a one-proton absorption at 
2.04 δ that is characteristic for a dibenzylic methanol hydroxyl proton but could possibly 
be acetone interference. The 5.85 – 6.00 δ (Figure 23) region shows the four singlet 
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proton absorptions that can correspond to the methylene protons of the new 1,3-
benzodioxole group, the single tertiary methanol proton, and the single tertiary 1,3-
dioxolane proton. There are five proton absorptions in the region 6.6 - 7.4 δ (Figure 24) 
that can be attributed to the five protons on the two aromatic rings. The original two 
singlet absorptions from the para protons of the starting material 26 have shifted from 
7.19 δ (Ar-3H), 6.96 δ (Ar-6H) to 6.89 δ and 6.79 δ, respectively. The 1,3-benzodioxol 
pendant group shows two ortho protons (Ar’-6H, 7H) as doublet absorptions 7.08 δ and 
6.68 δ, respectively and (Ar’-4H) singlet absorption at 6.79 δ. It is also interesting to note 
from 1H NMR (Figure 22) both the acetal (4.12 δ) and the TIPS (1.1-1.3 δ) protecting 
groups are still very much intact following the harsh lithium/halogen exchange 
environment. 
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The synthetic steps involved in the formation of the crucial intermediate 27 are 
suspect in a number of unwanted side reactions. The problems associated with the 
synthesis of intermediate 27 have been addressed repeatedly by previous researchers. The 
ability to synthesize 27 without producing major byproducts is one primary objective of 
this research. 
All research to date involved in the synthesis of intermediate alcohol 27 has relied 
upon the benzyl protecting group for the C4 hydroxyl of 16 prior to the lithium/halogen 
exchange step. The use of the benzyl protection, as was demonstrated by Schaff,4 
introduces additional metallation susceptible protons. Replacement of the benzyl group 
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with the TIPS protecting group could potentially eliminate this one extraneous 
metallation source. One advantage of having a TIPS protecting group at the C4 position 
of 26 is that it may introduce steric protection from α-lithiation (i.e., lithium hydrogen 
exchange) at C5. The C5 proton of 26 is susceptible to ortho-lithiation through the 
increased acidity induced by the adjacent bromine atom and also because of the lithium 
ion ability to coordinate with the C4 oxygen. Even though the lithium halogen exchange 
product at C6 of 26 is the favored outcome, the formation of an α-lithium product at C5 
or the benzyne intermediate are all possible outcomes. 
 
 16, R = Bn 
 26, R = TIPS 
 
 17, R = Bn 
 27, R = TIPS 
The molar ratios of butyllithium and piperonal used in the synthesis of 27 must be 
controlled as this can affect the product yields. Excess piperonal or butyllithium will lead 
to contaminant producing side reactions that will later prove difficult to remove from the 
desired product. In order to minimize the deleterious basic and nucleophilic effects of 
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butyllithium, the molar ratios of 26 to BuLi to piperonal must be maintained close to 
1:1:1. This requires a pure, dry, fresh 26, fresh BuLi, anhydrous THF, and a sealed inert 
atmosphere. 
The impure alcohol 27 was taken directly to the next cycloaddition step in order 
to generate the diester product 28, following a quick workup. The cycloaddition reaction 
procedure that was followed relied on a modified version of the Cleistanthin A patented 
process12 that was first used during the research work of Oude. This procedure required 
the use of the Q-Tube apparatus into which the alcohol 27, dimethyl acetylene-
dicarboxylate (DMAD), glacial acetic, and methylene chloride were introduced and then 
heated to 140° for one hour. The reactants were required at the molar ratios of 1:1:3.6 for 
27, DMAD, and HOAc, respectively. The molar quantity of 27 that was used as a starting 
material was not quantified since the crude product was not subjected to final purification 
but was estimated based upon the number of moles of starting material 26.  
The reaction product was then worked up as per the published procedure and 
finally concentrated under a reduced pressure to yield the crude 28. The 1H NMR spectra 
(Figure 25, spectra 1) of crude 28 shows a strong singlet proton absorption at 3.83 δ 
from unreacted DMAD, a singlet proton absorption at 12.32 δ corresponding to the new 
naphthalene C4 hydroxyl proton, and singlet proton absorptions of equal intensities at 
10.18 δ and 9.83 δ which are indicative of possible aldehyde byproducts. Absent is the 
methylene four proton multiplet at 4.06 δ from the 1,3-dioxolane protecting group of 27. 
The cycloaddition procedure was repeated five more times varying both the molar 












Table 2. Reaction conditions towards the production of 28. 
1H NMR Spectra 











1 2.00 1.70 2.37 12.90 1 
2 1.30 1.06 0.86 4.20 1 
3 3.00 2.75 1.58 15.20 21 
4  Spectra 3 w/ D2O 
5 1.37 2.00 1.00 6.80 85 
6 4.87 4.40 3.07 15.26 45 
7 4.10 3.86 3.07 15.26 84 
 
The six 1H NMR spectra (Figure 25) single proton absorptions at 12.32 δ as a 
result of the hydroxyl group appearance on the Ar-C4 of 28, were used to judge the 
overall reaction progress towards the targeted 28 diester product. The appearance of the 
proton absorption at 12.32 δ in the spectrum indicated the presence of 28. The 
confirmation that this absorption was due to the single aromatic hydroxyl proton is shown 
in Figure 25, spectra #4 following a D2O exchange of 28. The 1H NMR Figure 25 
spectra #4 can be seen showing the two singlet proton absorptions at 9.83 δ and 10.18 δ, 
but absent is the single proton absorption at 12.32 δ owing to a deuterated product of 28.  
The Diels-Alder cycloaddition reaction steps necessary to produce the diester 28 
from the chiral alcohol 27 are shown on page 28. In order to create the benzofuran 
intermediate from the protected alcohol 27, acetic acid is first used to catalyze the 
conversion of the acetal-protecting group back to the original aldehyde. The new 
aldehyde electrophile can now undergo an intramolecular condensation reaction leading 
to the benzofuran. The diene intermediate must be formed in order to complete the 
reaction cycloaddition sequence with the dienophile, DMAD to produce 28. Incomplete 
formation of 28 due to the α-lithiation product of 26 or unreacted 27 would ultimately 
leave aldehyde contaminants in the end product. 
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The 1H NMR spectra shown in Figure 25 indicated that all of the six reaction 
attempts had, indeed yielded measurable amounts of both 28 along with undesired 
byproducts. The 1 H NMR spectra of the first and subsequent reaction attempts can be 
seen in Figure 25, spectra # 1 up through and including the latest attempt in spectra # 7. 
The 1H NMR spectra of the most recent reaction also indicated a noticeable increase in 
the 28 hydroxyl proton absorbance at δ 12.32, absence of the byproduct proton 
absorbance at δ 10.18, and a much reduced byproduct proton absorbance at δ 9.83 when 
compared to all previous five reaction 1H NMR spectra. A noticeable improvement in the 
ratio of product 28 to the byproduct was seen in this most recent reaction and would later 
prove to be significant. The attempt to isolate 28 from the co-eluting contaminant 
byproducts, however, soon proved difficult utilizing the limited laboratory separation 
resources that were available. Variations in both column chromatography and acid-base 
extraction techniques were attempted but neither method yielded the desired product 
purity. The sterically demanding, non polar TIPS protecting group in place on the C7-
hydroxyl of the targeted compound 28 may have contributed to the compound’s 
indifference to base extraction separation. The same TIPS group on 28 might also be 
contributing to the increase in aprotic solvent phase mobility during column 
chromatography thereby preventing a capable mobile/stationary phase separation. 
However, after several weeks left standing, undisturbed the final reaction product, i.e. 
reaction 6, spectra # 7, began yielding isolated patches of crystallization in sufficient 
yield to be manually separated. The isolated yellow crystals were carefully cleaned with 
hexane and benzene on filter paper. After drying under vacuum the isolated crystalline 
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material was later identified through 1H NMR confirmation to be the targeted 28, pure 
enough for the ensuing butyrolactone ring creating reduction step. 
The 1H NMR spectrum of 28 (Figures 26, 27, 28, 29) shows an isopropylsilyl 
methyl eighteen proton doublet at δ 0.98, an isopropylsilyl methine three proton septet at 
δ 1.10, a methoxy methyl three proton singlet at δ 3.61, the dicarboxylate methyl three 
proton singlets at δ 3.93 and 3.97, the 1,3-benzodioxol methylene, one-proton doublets at 
δ 5.98 and δ 6.3, the 1,3-benzodioxole-6’H one proton doublet of doublets at δ 6.73, the -
4’H one proton doublet at δ 6.76, the -7’H one proton doublet at δ 6.86, the naphthalene 
5H and 8H one proton singlets at δ 6.81 and δ 7.70, respectively, and the naphthalene C4-
hydroxy, one proton singlet at δ12.31.The 13C NMR spectrum of 28 (Figure 30) shows 
the expected twenty four unique carbon absorptions for this compound. The 13C 
DEPT135 spectrum of 28 (Figure 31) shows the expected ten unique methyl/methine 
absorptions and the one unique methylene absorption. The HSQC spectrum (Figure 32, 
33) provides even further structural identification through the combined correlation of 
both the 1H NMR and the 13C NMR spectra. Through a combined comparison of the 13C 
NMR, 13C DEPT135, and the HSQC spectra the unique methyl, methylene, methine, and 
most quaternary carbon assignments can be made with a high degree of certainty. The 13C 
NMR (ppm) spectrum of 28 shows isopropylsilyl methine absorption at 12.63, 
isopropylsilyl methyl absorption at 17.71, carboxylate methyl absorptions at 51.92 and 
52.71, methoxy methyl absorption at 55.70, 1,3-benzodioxol methylene absorption at 
100.85, naphthalene C5 absorption at 103.3*, 1,3-benzodioxolane C7’ absorption at 
107.94, 1,3-benzodioxolane C4’ absorption at 111.29, naphthalene C8 absorption at 
120.34*, Ar-C absorption at 120.34*, 1,3-benzodioxolane C6’ absorption at 124.12, 1,3-
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benzodioxolane C5 absorption at 127.57*, naphthalene C3 absorption at 127.92*, Ar-C 
absorptions at 132.31*, 147.04*, 147.25*, 149.50*, 151.96*, 159.73*, naphthalene C4 
absorption at 159.73, carboxylate carbonyl absorptions at 169.42 and at 170.68  
CONCLUSIONS. 
A synthetic route towards the total synthesis of Haplomyrtin is achievable through 
the selective protection and deprotection of the reactant vulnerable sites on the starting 
material, vanillin. The durability of the TIPS group for hydroxyl protection and the cyclic 
acetal for aldehyde protection has exceeded our expectations. Both have proven their 
remarkable resistance to chemical attack under the harshest of reaction environments.  
The overall lower than expected yield of the targeted compound 1 is still at issue 
which could be due to the very nature of the synthetic process. Similar synthetic 
experimental attempts towards arylnapthalene production do not always produce the 
yields that we have come to expect. Overall yields of less than twenty percent (20%) for 
lithium-halogen exchange, nucleophilic substitution reactions, in general, are more the 
norm than the exception. At issue, with our synthetic yield, may not be just the lithium-
halogen exchange portion producing the alcohol 27 intermediate but more than likely the 
Diels-Alder cycloaddition sequence of reactions necessary to give the dicarboxylate 28. 
The cycloaddition events, or lack thereof, appear to still produce a good deal of the 
aldehyde contaminants in the Diels-Alder step. These contaminants might be from the 
remaining, deprotected, and unreacted 27 or they may be the carryover byproducts from 
the butyllithium sequence as was previously addressed by researchers Gilmore and 
Schaff. There might be several other causes for the failure of 27 not yielding 28. The 
condensation step of 27 will not occur with the α-lithiation product of 26. There might 
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also be just one enantiomer of the chiral 27 capable of the intramolecular condensation 
step. 
Improvements to the overall yield of Haplomyrtin 1 might be achieved through 
several changes. Reverse the order of the lithium-halogen exchange step by producing the 
protected piperonal carbanion and then reacting with the C4 protected vanillin. The use of 
cupric ion in the lithium-halogen reaction has been found to increase yields substantially 
in certain cases. Experimentation with varying types and amounts of the acid catalysts 
used in the cycloaddition step might yield more of the desired 28. Lastly, better 
separation methods and instrumentation tools should be made available in order to hasten 
isolation of the targeted product. 
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 Figure 7. 300 MHz 1H NMR Spectrum (CDCl3) of 9 ( BAV). Top 












Figure 9. 300 MHz 1H NMR Spectrum (CDCl3) of 8 (AV). 
 
 






























































Figure 19.  300 MHz 1H NMR spectral comparison of compound 26 reaction attempts 










































Figure 25. 300 MHz 1H NMR Spectra (CDCl3) of the six 28 reaction 
attempts. Spectra 4 is D2O exchange of 28. 
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Figure 32. HSQC correlation spectrum of 28. 
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